Healthy Opioid Prescription Engagement

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

November 8, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Opioid MisuseOpioid-Related DisordersPharmacist-Patient Relations
Interventions
BEHAVIORAL

Patient Navigation

PN involves 8 weekly telephonic sessions lasting 30-45 minutes (telephonic to support lower-costs/sustainability). In session 1, the navigator reviews with the participant a report of scores from the baseline assessment to understand the participant's current health needs/challenges; session 1 also involves development of therapeutic alliance/rapport and goal setting. Sessions 2-4 focus on goal setting and identifying barriers and problem resolutions. The navigator elicits motivation and discusses this in context of readiness to change heath behavior and self-management skills. Sessions 2-4 also involve navigators supporting/assisting patients to fill out paperwork and enroll in needed social services and/or mental/behavioral/physical healthcare, including but not limited to primary care. Sessions 5-7 focus on encouraging and reinforcing treatment adherence, review-ing and identifying other care needs, and offering linkages to service providers as applicable

OTHER

Standard Medication Counseling (SMC)

SMC participants receive a single medication information/counseling session delivered by a University of Utah pharmacist to: (1) offer counseling, (2) document counseling was offered, (3) offer a counseling process for patients not present (not applicable to this study given all patients must screen in person), and (4) discuss generic substitution.

Trial Locations (1)

84108

RECRUITING

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Jerry Cochran

OTHER